Dynavox Group (TDVXF) Fair Value & Analysis
Healthcare · US · Market cap $649M
Fair value as of: Jun 24, 2026
Analysis
Dynavox Group (TDVXF) currently trades at $6.20, while our model-based Fair Value estimate is $3.54 — implying the stock looks roughly 42.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its communication solutions include language, software, hardware, funding, support, and training. The company operates in Sweden, Norway, Denmark, Belgium, the United States, Germany, France, China, the United Kingdom, Ireland, Australia, and New Zealand. The company was formerly known as Tobii Dynavox AB (publ) and changed its name to Dynavox Group AB (publ) in July 2024. Dynavox Group AB (publ) was incorporated in 2012 and is headquartered in Stockholm, Sweden.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Dynavox Group (TDVXF) undervalued?
What is the fair value of TDVXF?
What is the quality score of TDVXF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.